Funded Startups in Amsterdam
Amsterdam's startup funding activity across the 50 most recent rounds spans May through November 2025, with deal flow concentrated in artificial intelligen…
Amsterdam's startup funding activity across the 50 most recent rounds spans May through November 2025, with deal flow concentrated in artificial intelligence, healthcare, and energy. AI appears as a primary or secondary sector in roughly 15 of the companies shown, from Overstory's $43M Series B and Oneleet's $33M Series A down to seed-stage names like Saga ($2M, legal AI) and Lleverage ($3M). The single largest round is Framer's $100M Series D in August 2025, followed by Avanzanite Bioscience ($37M Series A), Infinity Power ($40M private equity), and Leyden Labs ($35M) — all four closing between August and November 2025.
Early-stage volume runs thick alongside growth deals: 14 seed rounds and 8 pre-seed rounds are represented, most with ticket sizes below $3M. Healthcare forms a distinct vertical cluster, with Avanzanite Bioscience, myTomorrows, Fellos, Datamonk, and Open Health Technologies all closing rounds between September and November 2025. Deal pace accelerated toward year-end, with 11 rounds closing in November 2025 alone.
Most recent rounds
50 shownRelated listings
Frequently asked
What are the largest recent rounds closed by Amsterdam startups?
Framer leads with a $100M Series D in August 2025, followed by Overstory ($43M Series B, November 2025), Infinity Power ($40M private equity, November 2025), and Avanzanite Bioscience ($37M Series A, November 2025). Amdax and Leyden Labs both closed $35M rounds in early October 2025, and Tebi raised $34M in a Series B in June 2025.
How prominent is AI in Amsterdam's recent deal flow?
AI is tagged as a sector in roughly 15 of the 50 companies shown, spanning every stage from pre-seed — Yasu ($980K) and MarvelX ($6M) — through Series B (Overstory, $43M). B2B applications dominate the AI subset, with Saga (legal tech, $2M seed), Legal Mind ($870K seed), Struck (construction, $2M seed), and Dashmote (analytics, $6M Series A) among recent closings.
Which non-AI sectors are attracting significant capital in Amsterdam?
Healthcare and life sciences account for at least six companies closing rounds between September and November 2025: Avanzanite Bioscience ($37M Series A), myTomorrows ($29M private equity), and smaller deals at Fellos, Datamonk, Open Health Technologies, and Carepool. Energy is also active, with Infinity Power ($40M private equity) and Sympower ($22M Series B) both raising in that same window.
What does early-stage funding look like in Amsterdam across these deals?
The dataset includes 14 seed rounds and 8 pre-seed rounds, making early-stage deals the majority of disclosed activity. Pre-seed ticket sizes range from $770K (Northsea) to $6M (MarvelX), while seed rounds mostly fall between $350K and $8M — Aquablu at $8M sits at the high end. Six rounds across the full set are undisclosed.
How has Amsterdam deal pace looked month by month in recent data?
Eleven of the 50 rounds closed in November 2025, the highest single-month concentration in the dataset, followed by 12 rounds in October 2025 — that month alone included Amdax ($35M), Leyden Labs ($35M), Oneleet ($33M Series A), and Polars ($21M Series A). The oldest round shown dates to May 2025, placing all activity within roughly a six-month window.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.